Loading stock data…
ASP Isotopes Inc. (ASPI)
$4.20+0.30 (+7.69%)
Pre-Market$4.25+0.05 (+1.19%)· Last close Sep 4
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ASP Isotopes Inc. in the Basic Materials sector is trading at $4.20 with a market capitalization of $951M. Wall Street consensus targets $13.00 (3 analysts), implying a +209.5% move over the next 12 months. The stock is currently near its 52-week low of $3.51, remaining 24.2% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +209.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.18M↓ | $16.66M↑ | $4.89M↑ | $1.20M↑ | $1.10M |
| Gross Profit | $1.67M↓ | $2.08M↑ | $423,178↓ | $572,098↑ | $327,000 |
| Operating Income | -$24.89M↓ | -$22.30M↓ | -$14.97M↓ | -$11.97M↓ | -$7.95M |
| Net Income | -$6.88M↑ | -$78.71M↓ | -$12.87M↑ | -$75.06M↓ | -$8.45M |
Peer Comparison
Fundamentals
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isoto...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$950.57M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-60.04%
Volume
Today's trading volume
3.83M
Recent News
ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth
ASP Isotopes (NASDAQ:ASPI) expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference prese
ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed
ASP Isotopes (NASDAQ:ASPI) outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity’s 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026. Chief Commercial Officer Viktor Petko
ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production
ASP Isotopes (NASDAQ:ASPI) executives outlined plans to create a publicly listed helium and liquefied natural gas platform through Noble Africa, emphasizing Renergen’s South African helium resource, expected near-term production milestones and the proposed merger with ENDRA Life Sciences. Paul Mann
Reframing ASP Isotopes' (ASPI) Long-Term Strategy
In July 2026, ASP Isotopes Inc. filed a shelf registration to offer 23,160,682 shares of common stock, with an aggregate value of US$106.08 million. We will now examine how ASP Isotopes’ broader investment narrative is shaping up.
ASP Isotopes (ASPI) Files A Shelf Registration, Is The Stock Now Too Expensive?
ASP Isotopes (ASPI) has filed a shelf registration for up to US$106.1 million of common stock, covering 23,160,682 shares.